2010
DOI: 10.1590/s0066-782x2010000300025
|View full text |Cite
|
Sign up to set email alerts
|

Resistência à proteína C ativada e doença arterial isquêmica em jovem

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2013
2013

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…6,7 Inherited or acquired defects of coagulation system that cause hypercoagulability defined as thrombophilia including the anticardiolipin antibody, lupus anticoagulant, protein C and S deficiencies, factor V Leiden (FVL) and the G20210A mutation of the prothrombin gene. 9 The FVL is reported as the most common thrombophilia with a prevalence of 5% among the Caucasian population. The activated factor V acts as a cofactor to activated factor X in the conversion of prothrombin to thrombin and its function is down-regulated by the activated protein C (APC) for haemostatic maintenance.…”
Section: Casementioning
confidence: 99%
“…6,7 Inherited or acquired defects of coagulation system that cause hypercoagulability defined as thrombophilia including the anticardiolipin antibody, lupus anticoagulant, protein C and S deficiencies, factor V Leiden (FVL) and the G20210A mutation of the prothrombin gene. 9 The FVL is reported as the most common thrombophilia with a prevalence of 5% among the Caucasian population. The activated factor V acts as a cofactor to activated factor X in the conversion of prothrombin to thrombin and its function is down-regulated by the activated protein C (APC) for haemostatic maintenance.…”
Section: Casementioning
confidence: 99%